Decreased serum betatrophin may correlate with the improvement of obstructive sleep apnea after Roux-en-Y Gastric Bypass surgery
- PMID: 33469084
- PMCID: PMC7815868
- DOI: 10.1038/s41598-021-81379-1
Decreased serum betatrophin may correlate with the improvement of obstructive sleep apnea after Roux-en-Y Gastric Bypass surgery
Abstract
Obesity is strongly correlated with obstructive sleep apnea (OSA), and bariatric surgery can effectively treat obesity and alleviate OSA. However, the contributing factors are still unclear. We aimed to explore the relationship between betatrophin and OSA in patients undergoing Roux-en-Y gastric bypass (RYGB) surgery. Our study consisted of thirty-seven individuals with OSA and type 2 diabetes (16 males, 21 females) undergoing RYGB surgery. The polysomnography test, anthropometric results, serum betatrophin, and abdominal magnetic resonance images were evaluated both before and 1 year after RYGB surgery. Factors that may correlate with the alleviation of OSA were investigated. In our study, RYGB surgery significantly decreased apnea hypopnea index (AHI) and serum betatrophin concentration (p < 0.001). The abdominal visceral fat area, subcutaneous fat area and HOMA-IR were also significantly decreased (p < 0.001). The preoperative AHI, postoperative AHI and the change in AHI were significantly correlated with the preoperative betatrophin, postoperative betatrophin and the change in betatrophin, respectively (p < 0.05). These correlations were still significant after adjustment for other risk factors. The change in betatrophin was also independently associated with the change in minimum oxygen saturation (p < 0.001). Our data might indicate that serum betatrophin was significantly independently correlated with the improvement of OSA after bariatric surgery.
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Obstructive Sleep Apnea in a Chinese Population with Obesity and T2DM.Obes Surg. 2015 Aug;25(8):1446-53. doi: 10.1007/s11695-014-1510-9. Obes Surg. 2015. PMID: 25392079 Free PMC article. Clinical Trial.
-
Decreased serum betatrophin levels correlate with improved fasting plasma glucose and insulin secretion capacity after Roux-en-Y gastric bypass in obese Chinese patients with type 2 diabetes: a 1-year follow-up.Surg Obes Relat Dis. 2016 Aug;12(7):1343-1348. doi: 10.1016/j.soard.2016.01.024. Epub 2016 Jan 29. Surg Obes Relat Dis. 2016. PMID: 27178609
-
Circulating ANGPTL8/Betatrophin Concentrations Are Increased After Surgically Induced Weight Loss, but Not After Diet-Induced Weight Loss.Obes Surg. 2016 Aug;26(8):1881-9. doi: 10.1007/s11695-015-2026-7. Obes Surg. 2016. PMID: 26768268 Clinical Trial.
-
Endothelial Function of Patients with Morbid Obesity Submitted to Roux-en-Y Gastric Bypass With and Without Obstructive Sleep Apnea-Hypopnea Syndrome.Obes Surg. 2018 Nov;28(11):3595-3603. doi: 10.1007/s11695-018-3403-9. Obes Surg. 2018. PMID: 30054874
-
Roux-en-Y Gastric Bypass Surgery on Obstructive Sleep Apnea-Hypopnea Syndrome: Factors Associated with Postoperative Efficacy.Obes Surg. 2016 Dec;26(12):2924-2930. doi: 10.1007/s11695-016-2209-x. Obes Surg. 2016. PMID: 27165057
Cited by
-
Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.Int J Mol Sci. 2021 Nov 30;22(23):12945. doi: 10.3390/ijms222312945. Int J Mol Sci. 2021. PMID: 34884755 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials